# Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis

> **NCT04462536** · PHASE3 · COMPLETED · sponsor: **NoNO Inc.** · enrollment: 850 (actual)

## Conditions studied

- Stroke, Acute

## Interventions

- **DRUG:** Placebo
- **DRUG:** Nerinetide

## Key facts

- **NCT ID:** NCT04462536
- **Lead sponsor:** NoNO Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-06
- **Primary completion:** 2023-08-31
- **Final completion:** 2023-08-31
- **Target enrollment:** 850 (ACTUAL)
- **Last updated:** 2025-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04462536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04462536, "Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04462536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*